In the last trading session, 1.11 million Wave Life Sciences Ltd (NASDAQ:WVE) shares changed hands as the company’s beta touched -1.07. With the company’s per share price at $11.13 changed hands at -$0.14 or -1.24% during last session, the market valuation stood at $1.70B. WVE’s last price was a discount, traded about -50.4% off its 52-week high of $16.74. The share price had its 52-week low at $3.50, which suggests the last value was 68.55% up since then. When we look at Wave Life Sciences Ltd’s average trading volume, we note the 10-day average is 0.91 million shares, with the 3-month average coming to 1.48 million.
Analysts gave the Wave Life Sciences Ltd (WVE) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.20. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended WVE as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Instantly WVE was in red as seen at the end of in last trading. With action -14.58%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -10.02%, with the 5-day performance at -14.58% in the red. However, in the 30-day time frame, Wave Life Sciences Ltd (NASDAQ:WVE) is -27.77% down. Looking at the short shares, we see there were 8.21 million shares sold at short interest cover period of 7.85 days.
The consensus price target for the stock as assigned by Wall Street analysts is 22, meaning bulls need an upside of 49.41% from its current market value. According to analyst projections, WVE’s forecast low is 15 with 36 as the target high. To hit the forecast high, the stock’s price needs a -223.45% plunge from its current level, while the stock would need to soar -34.77% for it to hit the projected low.
Wave Life Sciences Ltd (WVE) estimates and forecasts
Data shows that the Wave Life Sciences Ltd share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 85.81% over the past 6 months, a -111.11% in annual growth rate that is considerably lower than the industry average of 16.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.03%. The 2025 estimates are for Wave Life Sciences Ltd earnings to decrease by -107.84%.
WVE Dividends
Wave Life Sciences Ltd is expected to release its next quarterly earnings report in February.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 15.04% of Wave Life Sciences Ltd shares while 79.36% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 93.40%. There are 79.36% institutions holding the Wave Life Sciences Ltd stock share, with RA CAPITAL MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 14.0527% of the shares, roughly 18.2 million WVE shares worth $90.83 million.
MAVERICK CAPITAL LTD holds the second largest percentage of outstanding shares, with 5.9211% or 7.67 million shares worth $38.27 million as of 2024-06-30.
Among Mutual Funds, the top two as of Oct 31, 2024 were Primecap Odyssey Aggressive Growth Fund and iShares Russell 2000 ETF . With 2.49 shares estimated at $27.77 million under it, the former controlled 1.64% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 1.31% of the shares, roughly 2.0 shares worth around $22.22 million.
